UNSPSC 51331900: Antipsychotic anions

Antipsychotic drugs made from negatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis.

UNSPSC 51331900 Antipsychotic anions is a Class code that does not align with the recent state and local procurement activity tagged under it. The three opportunities posted since early 2026 involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives and direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which fall within the scope of antipsychotic pharmaceutical compounds. The mismatch suggests either misclassification in the issuing bodies' tagging or a fundamental disconnect between the code's nominal scope and current procurement needs in state and local health systems.

The recent activity shows that health and human services agencies and cooperative purchasing alliances are actively soliciting pharmaceutical supply and distribution services, but these opportunities do not represent demand for antipsychotic anions specifically. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and safe drug deactivation systems; the Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities. The code shows no relevant recent activity for antipsychotic compounds and should be considered inactive for procurement purposes at this time.